Invesco’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13M | Sell |
173,019
-4,154
| -2% | -$267K | ﹤0.01% | 1766 |
|
|
2026
Q1 | $9.99M | Buy |
177,173
+8,448
| +5% | +$550K | ﹤0.01% | 1830 |
|
|
2025
Q4 | $13.5M | Buy |
168,725
+4,793
| +3% | +$322K | ﹤0.01% | 1672 |
|
|
2025
Q3 | $7.99M | Buy |
163,932
+55,282
| +51% | +$3.42M | ﹤0.01% | 1967 |
|
|
2025
Q2 | $8.11M | Buy |
108,650
+3,005
| +3% | +$199K | ﹤0.01% | 1918 |
|
|
2025
Q1 | $6.71M | Buy |
105,645
+9,654
| +10% | +$657K | ﹤0.01% | 2017 |
|
|
2024
Q4 | $7.49M | Sell |
95,991
-6,008
| -6% | -$483K | ﹤0.01% | 2034 |
|
|
2024
Q3 | $8.2M | Sell |
101,999
-15,082
| -13% | -$1.22M | ﹤0.01% | 1948 |
|
|
2024
Q2 | $9.69M | Buy |
117,081
+18,017
| +18% | +$1.58M | ﹤0.01% | 1810 |
|
|
2024
Q1 | $8.46M | Sell |
99,064
-616,804
| -86% | -$48.4M | ﹤0.01% | 1914 |
|
|
2023
Q4 | $61.2M | Sell |
715,868
-1,020
| -0.1% | -$88.2K | 0.01% | 922 |
|
|
2023
Q3 | $64.2M | Sell |
716,888
-63,305
| -8% | -$5.65M | 0.02% | 861 |
|
|
2023
Q2 | $66.4M | Buy |
780,193
+407,445
| +109% | +$34.4M | 0.02% | 849 |
|
|
2023
Q1 | $30.8M | Buy |
372,748
+252,906
| +211% | +$20.5M | 0.01% | 1155 |
|
|
2022
Q4 | $9.43M | Buy |
119,842
+6,998
| +6% | +$562K | ﹤0.01% | 1885 |
|
|
2022
Q3 | $8.35M | Buy |
112,844
+9,239
| +9% | +$663K | ﹤0.01% | 1915 |
|
|
2022
Q2 | $6.75M | Buy |
103,605
+8,979
| +9% | +$531K | ﹤0.01% | 2116 |
|
|
2022
Q1 | $5.98M | Buy |
94,626
+19,711
| +26% | +$1.07M | ﹤0.01% | 2284 |
|
|
2021
Q4 | $3.97M | Buy |
74,915
+1,087
| +1% | +$66.2K | ﹤0.01% | 2513 |
|
|
2021
Q3 | $5.21M | Sell |
73,828
-1,602
| -2% | -$101K | ﹤0.01% | 2362 |
|
|
2021
Q2 | $5.03M | Sell |
75,430
-122,672
| -62% | -$8.68M | ﹤0.01% | 2421 |
|
|
2021
Q1 | $22M | Buy |
198,102
+14,477
| +8% | +$1.79M | 0.01% | 1471 |
|
|
2020
Q4 | $21.8M | Buy |
183,625
+34,093
| +23% | +$3.67M | 0.01% | 1389 |
|
|
2020
Q3 | $13M | Sell |
149,532
-217,407
| -59% | -$19M | ﹤0.01% | 1521 |
|
|
2020
Q2 | $32.9M | Sell |
366,939
-477,007
| -57% | -$48.2M | 0.01% | 1080 |
|
|
2020
Q1 | $84.1M | Buy |
843,946
+127,502
| +18% | +$13.8M | 0.04% | 569 |
|
|
2019
Q4 | $82.3M | Sell |
716,444
-46,676
| -6% | -$5.65M | 0.03% | 763 |
|
|
2019
Q3 | $96.3M | Buy |
763,120
+327,528
| +75% | +$41.6M | 0.03% | 673 |
|
|
2019
Q2 | $52.4M | Buy |
435,592
+381,196
| +701% | +$37.5M | 0.01% | 1013 |
|
|
2019
Q1 | $4.76M | Sell |
54,396
-194,830
| -78% | -$17.7M | ﹤0.01% | 2039 |
|
|
2018
Q4 | $24.9M | Buy |
249,226
+58,800
| +31% | +$6.18M | 0.01% | 1044 |
|
|
2018
Q3 | $21.8M | Buy |
190,426
+23,970
| +14% | +$2.48M | 0.01% | 1220 |
|
|
2018
Q2 | $14.9M | Sell |
166,456
-175,252
| -51% | -$14.8M | ﹤0.01% | 1414 |
|
|
2018
Q1 | $25M | Sell |
341,708
-20,061
| -6% | -$1.38M | 0.01% | 1054 |
|
|
2017
Q4 | $21M | Buy |
361,769
+184,395
| +104% | +$9.71M | 0.01% | 1185 |
|
|
2017
Q3 | $7.96M | Buy |
177,374
+976
| +0.6% | +$40.5K | ﹤0.01% | 1703 |
|
|
2017
Q2 | $6.97M | Buy |
176,398
+13,019
| +8% | +$535K | ﹤0.01% | 1754 |
|
|
2017
Q1 | $6.63M | Buy |
163,379
+2,796
| +2% | +$109K | ﹤0.01% | 1796 |
|
|
2016
Q4 | $6.46M | Sell |
160,583
-11,840
| -7% | -$446K | ﹤0.01% | 1809 |
|
|
2016
Q3 | $6.24M | Sell |
172,423
-121,872
| -41% | -$4.18M | ﹤0.01% | 1833 |
|
|
2016
Q2 | $8.53M | Buy |
294,295
+52,848
| +22% | +$1.6M | ﹤0.01% | 1526 |
|
|
2016
Q1 | $8.45M | Buy |
241,447
+40,751
| +20% | +$1.32M | ﹤0.01% | 1507 |
|
|
2015
Q4 | $6.47M | Buy |
200,696
+9,883
| +5% | +$321K | ﹤0.01% | 1706 |
|
|
2015
Q3 | $6.17M | Sell |
190,813
-170,813
| -47% | -$6.43M | ﹤0.01% | 1718 |
|
|
2015
Q2 | $15M | Sell |
361,626
-335,799
| -48% | -$14.2M | 0.01% | 1344 |
|
|
2015
Q1 | $31.3M | Sell |
697,425
-560
| -0.1% | -$23.4K | 0.01% | 1011 |
|
|
2014
Q4 | $26.1M | Sell |
697,985
-33,624
| -5% | -$1.23M | 0.01% | 1078 |
|
|
2014
Q3 | $25.5M | Sell |
731,609
-16,076
| -2% | -$574K | 0.01% | 1091 |
|
|
2014
Q2 | $26.4M | Sell |
747,685
-15,291
| -2% | -$511K | 0.01% | 1099 |
|
|
2014
Q1 | $24.9M | Buy |
762,976
+10,144
| +1% | +$388K | 0.01% | 1103 |
|
|
2013
Q4 | $31.7M | Buy |
752,832
+24,816
| +3% | +$1.02M | 0.01% | 1016 |
|
|
2013
Q3 | $29M | Buy |
728,016
+44,727
| +7% | +$1.88M | 0.01% | 1007 |
|
|
2013
Q2 | $28.3M | Buy |
+683,289
| New | +$27.7M | 0.01% | 980 |
|
Other funds holding HAE
AI
Invesco's HAE Position: Q2 2026 in Review
Invesco reduced its Haemonetics (HAE) stake by 2.3% in Q2 2026, selling an estimated $267K and leaving 173,019 shares worth $13M. The position accounts for ﹤0.01% of the portfolio, ranked #1766.
Invesco first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $96.3M in Q3 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Invesco held 173,019 shares of Haemonetics worth $13M as of Q2 2026.
- Invesco sold 4,154 Haemonetics shares in Q2 2026, an estimated $267K.
- Haemonetics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #1766 holding.
- Invesco first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
- Invesco's Haemonetics position peaked at $96.3M in Q3 2019.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.